Monument Therapeutics

Bringing Precision Medicine to Neuroscience Drug Development

Founded 2019

Macclesfield, United Kingdom 6 employees Venture round Total: $4.13M Biotechnology, Health Care +1

General Information

Company Name Monument Therapeutics

Founded Year 2019

Location

Macclesfield, United Kingdom

Employees 6

Industries Biotechnology, Health Care, Pharmaceutical

Funding Stage Venture round

Business Model B2B, B2D

Revenue Model Licensing, Performance Based, Product Sales

Social

BounceWatch is an independent company data service, not affiliated with Monument Therapeutics. To contact Monument Therapeutics, visit monumenttx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Monument Therapeutics compare?

A PDF of Monument Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Monument Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Monument Therapeutics on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

United Kingdom Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in United Kingdom

Monument Therapeutics Alternatives

All Signals Trend Reports

About Monument Therapeutics

Monument Therapeutics, founded in 2019, is a forward-thinking biotechnology spin-out from Cambridge Cognition headquartered in the United Kingdom. The company positions itself at the intersection of health care and pharmaceutical industries with the goal of transforming neuroscience drug development through its slogan: "Bringing Precision Medicine to Neuroscience Drug Development".

Focused on addressing high unmet needs within the central nervous system, Monument Tx leverages proprietary digital biomarkers to minimize patient heterogeneity, thereby enhancing drug development efficacy. This precision medicine model emulates successful methodologies used in cancer treatment by identifying specific disease sub-types more likely to benefit from targeted compounds.

The company's latest financial milestone involved a £1.00M Venture Round investment on 18 April 2024, backed by noteworthy investor groups including Cambridge Angels group, SyndicateRoom, and Manchester Angels.

Business keywords: Precision Medicine, Neuroscience, Drug Development, Central Nervous System Disorders, Digital Biomarkers, Disease Sub-type Identification, Targeted Compounds, Pharmacogenomics, Spin-Out, UK-Based Company, Cambridge Cognition, Clinical Research, Neurobiology, Personalized Treatment

Services & Products

Development of targeted treatments for neuroscience conditions

Identification of suitable patients using digital biomarkers

Clinical drug development

Target Customers

Patients with cognitive impairments linked to schizophrenia Individuals with neuroinflammation Healthcare providers in psychiatry and neurology fields

Funding Rounds & Investors (3)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	£500.00K	1	Innovate UK	18 Apr 2024
Venture Round	£1.00M	3	Cambridge Angels group, SyndicateRoom +1	18 Apr 2024
Seed Round	£2.63M	4	Neo Kuma Ventures, GM&C Life Sciences Fund +2	01 Jul 2021

Latest News

View All

365 Finance secures £150M debt facility, Prosus' €4.1B acquisition of Just Eat Takeaway, and Web3 co... — Tech

365 Finance secures £150M debt facility, Prosus' €4.1B acquisition of Just Eat Takeaway, and Web3 companies to watch

Tech Feb 28, 2025

Monument Therapeutics secures £850K to advance schizophrenia treatment with MT1988

Tech Feb 25, 2025

Monument Therapeutics Alternatives & Competitors

View All Alternatives

Monument Therapeutics vs

Novoron Bioscience United States

Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spi...

Seed

17 employees

Biopharma, Biotechnology

Monument Therapeutics vs

Emalex Biosciences United States

Improving people's lives impacted by central nervous system disorders through meaningful scientific...

Series D

54 employees

Biopharma, Biotechnology

Monument Therapeutics vs

Acadia Pharmaceuticals United States

Acadia is trailblazing breakthroughs in neuroscience to elevate life.

Post-IPO Equity

1028 employees

Biotechnology, Health Care

Also compare with:

SynapCell View all alternatives

FAQ About Monument Therapeutics

Bringing Precision Medicine to Neuroscience Drug Development

Monument Therapeutics was founded in 2019.

Monument Therapeutics is headquartered in Macclesfield, United Kingdom.

Monument Therapeutics operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Precision Medicine, Neuroscience, Drug Development and Central Nervous System Disorders. Its customers include Patients with cognitive impairments linked to schizophrenia, Individuals with neuroinflammation and Healthcare providers in psychiatry and neurology fields.

Monument Therapeutics has a B2B and B2D business model. Its revenue comes from Licensing, Performance Based and Product Sales.

Monument Therapeutics has approximately 6 employees.

Monument Therapeutics has completed 3 funding rounds, raising a total of $4.13M. The latest funding stage is Venture round.

Monument Therapeutics offers: Development of targeted treatments for neuroscience conditions, Identification of suitable patients using digital biomarkers, Clinical drug development.

Top alternatives and competitors to Monument Therapeutics include Novoron Bioscience, Emalex Biosciences, Acadia Pharmaceuticals, vTv Therapeutics, Cerebral Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Monument Therapeutics and Novoron Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Monument Therapeutics, https://bouncewatch.com/company/monument-therapeutics, updated 25 September 2026. When citing, please name BounceWatch and link this page.